SlideShare a Scribd company logo
1 of 53
Understanding Statistical
Power for Non-Statisticians
WEBINAR | JUNE 28, 2016 | 12:00PM EASTERN | DIA 2016
DALE W. USNER, PH.D. | PRESIDENT | SDC
General Housekeeping
 Use mic & speakers or call in
 Webinar users submit questions
via chat
Dale W. Usner, Ph.D.
 20 years in industry
 50+ FDA and international regulatory body
interactions
 Frequent study design support
 Therapeutic Expertise
Anti-viral/Anti-infective, Cardiovascular, Gastrointestinal,
Oncology/Immunology, Ophthalmology, Surgical, Other
Agenda
 What is Statistical Power
 How Assumptions Affect Statistical Power and Sample Size
 How Power Is Associated With What is Statistically Significant
 Q&A
What is
Statistical
Power?
What is Statistical Power?
 Clinical/Medical: If I want to compare our Test Product
to the Control Product in systolic blood pressure, what
sample size will I need?
 Statistician: Assuming a Difference in Means of 10 mm
Hg and a common Standard Deviation (SD) of 20 mm
Hg, 64 subjects per treatment group are required to
have 80% power for a 2-sided  = 0.05 test.
What is Statistical Power?
Next?
What is Statistical Power? Questions
 What does it mean to have 80% power?
What is Statistical Power? Questions
 What does it mean to have 80% power?
 What does it mean to assume a difference in means of
10 mm Hg? What if the true diff <10? >10?
What is Statistical Power? Questions
 What does it mean to have 80% power?
 What does it mean to assume a difference in means of
10 mm Hg? What if the true diff <10? >10?
 What role does the SD play? What if the true SD is >20?
What if the true SD is <20?
What is Statistical Power? Questions
 What does it mean to have 80% power?
 What does it mean to assume a difference in means of
10 mm Hg? What if the true diff <10? >10?
 What role does the SD play? What if the true SD is >20?
What if the true SD is <20?
 What happens if the difference observed in the study is
<10 mm Hg?
Motivation
 Assuming a Difference in Means of 10 mm Hg and a
common SD of 20 mm Hg, N = 64 subjects per
treatment group are required to have 80% power for a
2-sided  = 0.05 test.
 The study will demonstrate a statistically significant
result if the difference observed in the study is ≥7.0 mm
Hg (assuming the observed SD is 20 mm Hg).
Motivation
 With 85% Power (N = 73 subjects / Tx Gp) observed
differences ≥6.55 mm Hg would yield statistical
significance
 With 90% Power (N = 86 subjects / Tx Gp) observed
differences ≥6.03 mm Hg would be statistical
significance
Background
Statistical Inference
 Statistical Inference: Drawing conclusions
about an entire population based on a
sample from that population.
Hypotheses (Efficacy)
Superiority
 H0: Test Arm is no different from Control Arm
 H1: Test Arm is different (superior) than Control Arm
Non-Inferiority
 H0: Test Arm is inferior to Control Arm
 H1: Test Arm is non-inferior to Control Arm
Desired Outcome: Reject H0 in favor of H1
Statistical Inference: Coin Flip
 H0: Proportion of Heads = Prop Tails = 0.50
 H1: Proportion of Heads > Prop Tails
 Flip a coin 4 times with result 3H and 1T. 75% Heads,
should H0 be rejected?
Statistical Inference: Coin Flip
 H0: Proportion of Heads = Prop Tails = 0.50
 H1: Proportion of Heads > Prop Tails
 Flip a coin 4 times with result 3H and 1T. 75% Heads,
should H0 be rejected?
 No, probability of this occurring under H0 is 31.25%
Statistical Inference: Coin Flip
 H0: Proportion of Heads = Prop Tails = 0.50
 H1: Proportion of Heads > Prop Tails
 Flip a coin 4 times with result 3H and 1T. 75% Heads,
should H0 be rejected?
 No, probability of this occurring under H0 is 31.25%
 Flip a coin 40 times with result 30H and 10T. 75%
Heads, should H0 be rejected?
Statistical Inference: Coin Flip
 H0: Proportion of Heads = Prop Tails = 0.50
 H1: Proportion of Heads > Prop Tails
 Flip a coin 4 times with result 3H and 1T. 75% Heads,
should H0 be rejected?
 No, probability of this occurring under H0 is 31.25%
 Flip a coin 40 times with result 30H and 10T. 75%
Heads, should H0 be rejected?
 Yes, probability of this occurring under H0 is <0.1%
Define  and Power
  (Type I Error) is the probability that the study
concludes the Test Arm is different from the Control
Arm, when the Test Arm truly is no different. This is a
regulatory risk.
 Power is the probability that the study concludes the
Test Arm is different from the Control Arm, when in
the Test Arm truly is different. This is sponsor risk.
Continuous & Binary Measures
 Continuous Measures
 Generally testing differences in Means or Medians
 Standard Deviation also very important
 Binary Measures
 Generally testing differences or ratios of proportions
 Standard Deviations generally determined by assumed
proportions
Power in Pictures
 Consider
 a therapy designed to lower systolic blood pressure
(SysBP) by an additional 10 mm Hg more than the
currently best selling therapy, which has been shown to
lower the SysBP to an average of 140 mm Hg.
 that each treatment has an SD of 20 mm Hg
 Assume the data follow normal distributions
Power in Pictures: Sample Size = 1
Power in Pictures: Sample Size = 5
Power in Pictures: Sample Size = 10
Power in Pictures: Sample Size = 30
Power in Pictures: Sample Size = 50
Power in Pictures: Sample Size = 64
Power in Pictures: Sample Size = 73
Power in Pictures: Sample Size = 86
Power in Pictures: Sample Size = 1
Power in Pictures: Sample Size = 5
Power: 10%
Power in Pictures: Sample Size = 10
Power: 18%
Power in Pictures: Sample Size = 30
Power: 47%
Power in Pictures: Sample Size = 50
Power: 69%
Power in Pictures: Sample Size = 64
Power: 80%
Power in Pictures: Sample Size = 73
Power: 85%
Power in Pictures: Sample Size = 86
Power: 90%
Standard Powers
 80%: If the test product is as efficacious as assumed
under H1, 80% of trials should reject H0 in favor of H1
by design. Generally considered to be the lowest
targeted power.
 85%: 85% of trials should reject H0 in favor of H1 by
design.
 90%: 90% of trials should reject H0 in favor of H1 by
design.
Sponsor Risk
 80%: If the test product is as efficacious as assumed
under H1, 20% of trials will fail to reject H0 in favor of
H1 by design.
 85%: 15% of trials will fail to reject H0 in favor of H1 by
design.
 90%: 10% of trials will fail to reject H0 in favor of H1 by
design.
How Assumptions Affect
Statistical Power and
Sample Size
Sample Size x Assumed Difference x
Power
0
100
200
300
400
500
6 7 8 9 10 11 12 13 14
TotalSampleSize
Assumed Difference
SD = 20, 2-sided alpha = 0.05
80% Power
85% Power
% Increase in Sample Size (N) for
Increasing Power
 Assuming a 2-sided  = 0.05 test, N increases by:
 ~14% from 80% to 85% power
 ~34% from 80% to 90% power
 Assuming a 2-sided  = 0.10 test, N increases by
 ~16% from 80% to 85% power
 ~38% from 80% to 90% power
 Assuming a 2-sided  = 0.20 test, N increases by
 ~19% from 80% to 85% power
 ~46% from 80% to 90% power
Sample Size x Assumed Difference x
Standard Deviation
0
100
200
300
400
500
600
6 7 8 9 10 11 12 13 14
TotalSampleSize
Assumed Difference
80% Power, 2-sided alpha = 0.05
SD = 16
SD = 18
SD = 20
SD = 22
% Increase in Sample Size (N) for
Increasing Standard Deviation
 Regardless of the  and power, N increases by a factor of
(SDhigh / SDlow)2
Sample Size x Assumed Difference x
Alpha (Type I Error)
0
100
200
300
400
6 7 8 9 10 11 12 13 14
TotalSampleSize
Assumed Difference
SD = 20, 80% Power
2-sided alpha = 0.20
2-sided alpha = 0.10
% Decrease in Sample Size (N) for
Increasing Alpha (Type I Error)
 Assuming 80% power, N decreases by:
 ~21% from 2-sided alpha = 0.05 to 0.10
 ~42% from 2-sided alpha = 0.05 to 0.20
 Assuming 85% power, N decreases by:
 ~20% from 2-sided alpha = 0.05 to 0.10
 ~40% from 2-sided alpha = 0.05 to 0.20
 Assuming 90% power, N decreases by:
 ~18% from 2-sided alpha = 0.05 to 0.10
 ~37% from 2-sided alpha = 0.05 to 0.20
Sample Size x Assumed Difference x
Power and Ratio of Randomization
0
100
200
300
400
500
600
6 7 8 9 10 11 12 13 14
TotalSampleSize
Assumed Difference
SD = 20, 2-sided alpha = 0.05
80% Power
80% Power 2:1
85% Power
85% Power 2:1
% Increase in Sample Size (N) for
Increasing Randomization Ratio
 Regardless of the  and power, N increases by:
 ~4.2% from 1:1 to 3:2 randomization ratio
 ~12.5% from 1:1 to 2:1 randomization ratio
 ~33.3% from 1:1 to 3:1 randomization ratio
% Decrease in Min Obs Diff Required for
Significance with Increasing N
 Regardless of the , the Minimum Observed Difference
required for Significance decreases by a factor of sqrt(Nlow /
Nhigh)
 With 80% Power, N = 64 / Tx Group required diff is 7.00 mm Hg
 With 85% Power, N = 73 / Tx Group required diff is
(7.00*sqrt(64/73)) = 6.55 mm Hg
 With 90% Power, N = 86 / Tx Group required diff is
(7.00*sqrt(64/86)) = 6.03 mm Hg
Effect on Statistical Significance
 Increasing Sample Size decreases the minimum
difference required to show statistical significance
(driven by H0) and therefore increases power.
 Required sample size increases with:
 Increasing: Power, SD, Randomization Ratio
 Decreasing: Alpha, Assumed Difference
Thank You
info@sdcclinical.com
www.sdcclinical.com
Q&A

More Related Content

What's hot

ESS Internal Assessment Rubric
ESS Internal Assessment RubricESS Internal Assessment Rubric
ESS Internal Assessment RubricBrad Kremer
 
Ib ess guidelines for lab design
Ib ess guidelines for lab designIb ess guidelines for lab design
Ib ess guidelines for lab designGURU CHARAN KUMAR
 
Statistical inference
Statistical inferenceStatistical inference
Statistical inferenceJags Jagdish
 
Lab report templete
Lab report templeteLab report templete
Lab report templeteSofia Paz
 
Lab report templante for 10th and 9th grade
Lab report templante for 10th and 9th gradeLab report templante for 10th and 9th grade
Lab report templante for 10th and 9th gradeSofia Paz
 
PG STAT 531 Lecture 4 Exploratory Data Analysis
PG STAT 531 Lecture 4 Exploratory Data AnalysisPG STAT 531 Lecture 4 Exploratory Data Analysis
PG STAT 531 Lecture 4 Exploratory Data AnalysisAashish Patel
 
Data Analysis and Statistics
Data Analysis and StatisticsData Analysis and Statistics
Data Analysis and StatisticsT.S. Lim
 
Statistics pres 10 27 2015 roy sabo
Statistics pres 10 27 2015   roy saboStatistics pres 10 27 2015   roy sabo
Statistics pres 10 27 2015 roy sabotjcarter
 
Cenduit_Whitepaper_Forecasting_Present_14June2016
Cenduit_Whitepaper_Forecasting_Present_14June2016Cenduit_Whitepaper_Forecasting_Present_14June2016
Cenduit_Whitepaper_Forecasting_Present_14June2016Praveen Chand
 
Confidently Conduct and Write Your Power Analysis
Confidently Conduct and Write Your Power AnalysisConfidently Conduct and Write Your Power Analysis
Confidently Conduct and Write Your Power AnalysisStatistics Solutions
 
Project two guidelines and rubric.html competencyin this pr
Project two guidelines and rubric.html competencyin this prProject two guidelines and rubric.html competencyin this pr
Project two guidelines and rubric.html competencyin this prPOLY33
 
Statistical Analysis Overview
Statistical Analysis OverviewStatistical Analysis Overview
Statistical Analysis OverviewEcumene
 
Statistical inference concept, procedure of hypothesis testing
Statistical inference   concept, procedure of hypothesis testingStatistical inference   concept, procedure of hypothesis testing
Statistical inference concept, procedure of hypothesis testingAmitaChaudhary19
 
2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - Final2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - FinalBrian Lin
 
Statistics for IB Biology
Statistics for IB BiologyStatistics for IB Biology
Statistics for IB BiologyEran Earland
 
Statistics for Business Decision-making
Statistics for Business Decision-makingStatistics for Business Decision-making
Statistics for Business Decision-makingJason Martuscello
 
Predictive Modeling Workshop
Predictive Modeling WorkshopPredictive Modeling Workshop
Predictive Modeling Workshopodsc
 
Exploratory data analysis
Exploratory data analysisExploratory data analysis
Exploratory data analysisgokulprasath06
 

What's hot (20)

ESS Internal Assessment Rubric
ESS Internal Assessment RubricESS Internal Assessment Rubric
ESS Internal Assessment Rubric
 
Ib ess guidelines for lab design
Ib ess guidelines for lab designIb ess guidelines for lab design
Ib ess guidelines for lab design
 
Statistical inference
Statistical inferenceStatistical inference
Statistical inference
 
Lab report templete
Lab report templeteLab report templete
Lab report templete
 
Lab report templante for 10th and 9th grade
Lab report templante for 10th and 9th gradeLab report templante for 10th and 9th grade
Lab report templante for 10th and 9th grade
 
Statistical analysis and its applications
Statistical analysis and its applicationsStatistical analysis and its applications
Statistical analysis and its applications
 
PG STAT 531 Lecture 4 Exploratory Data Analysis
PG STAT 531 Lecture 4 Exploratory Data AnalysisPG STAT 531 Lecture 4 Exploratory Data Analysis
PG STAT 531 Lecture 4 Exploratory Data Analysis
 
Data Analysis and Statistics
Data Analysis and StatisticsData Analysis and Statistics
Data Analysis and Statistics
 
Statistics pres 10 27 2015 roy sabo
Statistics pres 10 27 2015   roy saboStatistics pres 10 27 2015   roy sabo
Statistics pres 10 27 2015 roy sabo
 
Cenduit_Whitepaper_Forecasting_Present_14June2016
Cenduit_Whitepaper_Forecasting_Present_14June2016Cenduit_Whitepaper_Forecasting_Present_14June2016
Cenduit_Whitepaper_Forecasting_Present_14June2016
 
Confidently Conduct and Write Your Power Analysis
Confidently Conduct and Write Your Power AnalysisConfidently Conduct and Write Your Power Analysis
Confidently Conduct and Write Your Power Analysis
 
Project two guidelines and rubric.html competencyin this pr
Project two guidelines and rubric.html competencyin this prProject two guidelines and rubric.html competencyin this pr
Project two guidelines and rubric.html competencyin this pr
 
Statistical Analysis Overview
Statistical Analysis OverviewStatistical Analysis Overview
Statistical Analysis Overview
 
Mkt research
Mkt researchMkt research
Mkt research
 
Statistical inference concept, procedure of hypothesis testing
Statistical inference   concept, procedure of hypothesis testingStatistical inference   concept, procedure of hypothesis testing
Statistical inference concept, procedure of hypothesis testing
 
2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - Final2016 Symposium Poster - statistics - Final
2016 Symposium Poster - statistics - Final
 
Statistics for IB Biology
Statistics for IB BiologyStatistics for IB Biology
Statistics for IB Biology
 
Statistics for Business Decision-making
Statistics for Business Decision-makingStatistics for Business Decision-making
Statistics for Business Decision-making
 
Predictive Modeling Workshop
Predictive Modeling WorkshopPredictive Modeling Workshop
Predictive Modeling Workshop
 
Exploratory data analysis
Exploratory data analysisExploratory data analysis
Exploratory data analysis
 

Viewers also liked

Power, effect size, and Issues in NHST
Power, effect size, and Issues in NHSTPower, effect size, and Issues in NHST
Power, effect size, and Issues in NHSTCarlo Magno
 
Chapter 8 – Hypothesis Testing
Chapter 8 – Hypothesis TestingChapter 8 – Hypothesis Testing
Chapter 8 – Hypothesis TestingRose Jenkins
 
APA Basics: Citations
APA Basics: CitationsAPA Basics: Citations
APA Basics: Citationsrallen432
 
Apa citing, paraphrasing and quoting presentation
Apa citing, paraphrasing and quoting presentationApa citing, paraphrasing and quoting presentation
Apa citing, paraphrasing and quoting presentationSuhartini Syukrie
 
APA research paper format
APA research paper formatAPA research paper format
APA research paper formatEssayAcademy
 
What Is APA
What Is APAWhat Is APA
What Is APAkeylibbw
 
Power, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic IntegrityPower, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic IntegrityJames Neill
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introductionbiinoida
 
Clinical trials flow process
Clinical trials flow processClinical trials flow process
Clinical trials flow processTamer Hifnawy
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical researchPradeep H
 
Clinical research ppt,
Clinical research   ppt,Clinical research   ppt,
Clinical research ppt,Malay Singh
 
Methods of data collection
Methods of data collectionMethods of data collection
Methods of data collectionsimij
 
Ppt on Report Writing
Ppt on  Report WritingPpt on  Report Writing
Ppt on Report WritingShruti Mishra
 

Viewers also liked (20)

Power, effect size, and Issues in NHST
Power, effect size, and Issues in NHSTPower, effect size, and Issues in NHST
Power, effect size, and Issues in NHST
 
K to 12 Curriculum Guide for Kindergarten
K to 12 Curriculum Guide for KindergartenK to 12 Curriculum Guide for Kindergarten
K to 12 Curriculum Guide for Kindergarten
 
Marketing Research
Marketing ResearchMarketing Research
Marketing Research
 
Chapter 8 – Hypothesis Testing
Chapter 8 – Hypothesis TestingChapter 8 – Hypothesis Testing
Chapter 8 – Hypothesis Testing
 
APA Basics: Citations
APA Basics: CitationsAPA Basics: Citations
APA Basics: Citations
 
Apa citing, paraphrasing and quoting presentation
Apa citing, paraphrasing and quoting presentationApa citing, paraphrasing and quoting presentation
Apa citing, paraphrasing and quoting presentation
 
APA research paper format
APA research paper formatAPA research paper format
APA research paper format
 
What Is APA
What Is APAWhat Is APA
What Is APA
 
MLA, APA
MLA, APAMLA, APA
MLA, APA
 
MLA vs APA
MLA vs APAMLA vs APA
MLA vs APA
 
Power, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic IntegrityPower, Effect Sizes, Confidence Intervals, & Academic Integrity
Power, Effect Sizes, Confidence Intervals, & Academic Integrity
 
Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
 
Clinical trials flow process
Clinical trials flow processClinical trials flow process
Clinical trials flow process
 
Introduction to clinical research
Introduction to clinical researchIntroduction to clinical research
Introduction to clinical research
 
RESEARCH WRITING - Apa References Style
RESEARCH WRITING - Apa References StyleRESEARCH WRITING - Apa References Style
RESEARCH WRITING - Apa References Style
 
Clinical research ppt,
Clinical research   ppt,Clinical research   ppt,
Clinical research ppt,
 
Clinical Trial Phases
Clinical Trial PhasesClinical Trial Phases
Clinical Trial Phases
 
Methods of data collection
Methods of data collectionMethods of data collection
Methods of data collection
 
Sampling
SamplingSampling
Sampling
 
Ppt on Report Writing
Ppt on  Report WritingPpt on  Report Writing
Ppt on Report Writing
 

Similar to Understanding Statistical Power for Non-Statisticians

Similar to Understanding Statistical Power for Non-Statisticians (20)

Biostatistics
BiostatisticsBiostatistics
Biostatistics
 
Lect w7 t_test_amp_chi_test
Lect w7 t_test_amp_chi_testLect w7 t_test_amp_chi_test
Lect w7 t_test_amp_chi_test
 
Cairo 02 Stat Inference
Cairo 02 Stat InferenceCairo 02 Stat Inference
Cairo 02 Stat Inference
 
HypothesisTesting_HANDOUT.pdf
HypothesisTesting_HANDOUT.pdfHypothesisTesting_HANDOUT.pdf
HypothesisTesting_HANDOUT.pdf
 
Displaying your results
Displaying your resultsDisplaying your results
Displaying your results
 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
 
Uplift Modeling Workshop
Uplift Modeling WorkshopUplift Modeling Workshop
Uplift Modeling Workshop
 
Clinical Trial Statstics 2016
Clinical Trial Statstics 2016Clinical Trial Statstics 2016
Clinical Trial Statstics 2016
 
Chapter08
Chapter08Chapter08
Chapter08
 
Sampling
SamplingSampling
Sampling
 
31st july talk (20021)
31st july talk (20021)31st july talk (20021)
31st july talk (20021)
 
Statistical analysis
Statistical analysisStatistical analysis
Statistical analysis
 
Test hypothesis
Test hypothesisTest hypothesis
Test hypothesis
 
SNM-1.pdf
SNM-1.pdfSNM-1.pdf
SNM-1.pdf
 
Quantitative_analysis.ppt
Quantitative_analysis.pptQuantitative_analysis.ppt
Quantitative_analysis.ppt
 
Proportion test using Chi square
Proportion test using Chi squareProportion test using Chi square
Proportion test using Chi square
 
Lesson07_new
Lesson07_newLesson07_new
Lesson07_new
 
Basics of medical statistics
Basics of medical statisticsBasics of medical statistics
Basics of medical statistics
 
Two sample t-test
Two sample t-testTwo sample t-test
Two sample t-test
 
STATISTIC ESTIMATION
STATISTIC ESTIMATIONSTATISTIC ESTIMATION
STATISTIC ESTIMATION
 

More from Statistics & Data Corporation

Handling of Missing Data in Clinical Trials for Non-Statisticians
Handling of Missing Data in Clinical Trials for Non-StatisticiansHandling of Missing Data in Clinical Trials for Non-Statisticians
Handling of Missing Data in Clinical Trials for Non-StatisticiansStatistics & Data Corporation
 
Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17
Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17
Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17Statistics & Data Corporation
 
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROsWebinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROsStatistics & Data Corporation
 
A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...
A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...
A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...Statistics & Data Corporation
 
iMedNet EDC Maximizes eClinical Development Process Efficiency
iMedNet EDC Maximizes eClinical Development Process EfficiencyiMedNet EDC Maximizes eClinical Development Process Efficiency
iMedNet EDC Maximizes eClinical Development Process EfficiencyStatistics & Data Corporation
 
ARVO 2015 Poster Presentation by Kirk Bateman, Director, Biostatistics
ARVO 2015 Poster Presentation by Kirk Bateman, Director, BiostatisticsARVO 2015 Poster Presentation by Kirk Bateman, Director, Biostatistics
ARVO 2015 Poster Presentation by Kirk Bateman, Director, BiostatisticsStatistics & Data Corporation
 
Retina Today (Nov-Dec 2014): The Clinical Data Management Process
Retina Today (Nov-Dec 2014): The Clinical Data Management ProcessRetina Today (Nov-Dec 2014): The Clinical Data Management Process
Retina Today (Nov-Dec 2014): The Clinical Data Management ProcessStatistics & Data Corporation
 
"Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp...
"Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp..."Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp...
"Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp...Statistics & Data Corporation
 
Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...
Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...
Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...Statistics & Data Corporation
 

More from Statistics & Data Corporation (12)

Handling of Missing Data in Clinical Trials for Non-Statisticians
Handling of Missing Data in Clinical Trials for Non-StatisticiansHandling of Missing Data in Clinical Trials for Non-Statisticians
Handling of Missing Data in Clinical Trials for Non-Statisticians
 
Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17
Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17
Webinar | Site Relationships: Why They Matter and How to Foster Them 1-31-17
 
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROsWebinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
Webinar: How to Ace Your SaaS-based EDC System Validation for Sponsors and CROs
 
A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...
A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...
A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs an...
 
iMedNet EDC Maximizes eClinical Development Process Efficiency
iMedNet EDC Maximizes eClinical Development Process EfficiencyiMedNet EDC Maximizes eClinical Development Process Efficiency
iMedNet EDC Maximizes eClinical Development Process Efficiency
 
ARVO 2015 Poster Presentation by Kirk Bateman, Director, Biostatistics
ARVO 2015 Poster Presentation by Kirk Bateman, Director, BiostatisticsARVO 2015 Poster Presentation by Kirk Bateman, Director, Biostatistics
ARVO 2015 Poster Presentation by Kirk Bateman, Director, Biostatistics
 
Retina Today (Nov-Dec 2014): The Clinical Data Management Process
Retina Today (Nov-Dec 2014): The Clinical Data Management ProcessRetina Today (Nov-Dec 2014): The Clinical Data Management Process
Retina Today (Nov-Dec 2014): The Clinical Data Management Process
 
"Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp...
"Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp..."Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp...
"Efficacy and Safety of Treatment with an Anti‐M2e Monoclonal Antibody in Exp...
 
Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...
Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...
Shannon Labout Presenting at MAGI Clinical Research Conference - Las Vegas, 2...
 
SDC Booth June 2013
SDC Booth June 2013SDC Booth June 2013
SDC Booth June 2013
 
SDTM and CDASH Training with Shannon Labout
SDTM and CDASH Training with Shannon LaboutSDTM and CDASH Training with Shannon Labout
SDTM and CDASH Training with Shannon Labout
 
What We Need to Know About CDISC
What We Need to Know About CDISCWhat We Need to Know About CDISC
What We Need to Know About CDISC
 

Recently uploaded

FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxMumux Mirani
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology InsightsHealth Catalyst
 
Call Girl Bangalore Aashi 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Aashi 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Aashi 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Aashi 7001305949 Independent Escort Service Bangalorenarwatsonia7
 
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...stina6279
 
Call Girls South Delhi 9999965857 Cheap and Best with original Photos
Call Girls South Delhi 9999965857 Cheap and Best with original PhotosCall Girls South Delhi 9999965857 Cheap and Best with original Photos
Call Girls South Delhi 9999965857 Cheap and Best with original Photosparshadkalavatidevi7
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Doveagatadrynko
 
Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 ) unlimited hard...
Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 )  unlimited hard...Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 )  unlimited hard...
Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 ) unlimited hard...ggsonu500
 
Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxShubham
 
Models Call Girls Electronic City | 7001305949 At Low Cost Cash Payment Booking
Models Call Girls Electronic City | 7001305949 At Low Cost Cash Payment BookingModels Call Girls Electronic City | 7001305949 At Low Cost Cash Payment Booking
Models Call Girls Electronic City | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
SARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdf
SARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdfSARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdf
SARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdfDolisha Warbi
 
Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949ps5894268
 
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed RuleShelby Lewis
 
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...narwatsonia7
 
Call Girls Sawda 9999965857 Cheap and Best with original Photos
Call Girls Sawda 9999965857 Cheap and Best with original PhotosCall Girls Sawda 9999965857 Cheap and Best with original Photos
Call Girls Sawda 9999965857 Cheap and Best with original Photoskartikkumark7k7
 
9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Delivery
9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Delivery9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Delivery
9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Deliverymarshasaifi
 
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...vrvipin164
 
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 HireCall Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 HireCall Girls Delhi
 
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...ggsonu500
 
Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...ggsonu500
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 

Recently uploaded (20)

FAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptxFAMILY in sociology for physiotherapists.pptx
FAMILY in sociology for physiotherapists.pptx
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights
 
Call Girl Bangalore Aashi 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Aashi 7001305949 Independent Escort Service BangaloreCall Girl Bangalore Aashi 7001305949 Independent Escort Service Bangalore
Call Girl Bangalore Aashi 7001305949 Independent Escort Service Bangalore
 
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 72 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
Call Girls South Delhi 9999965857 Cheap and Best with original Photos
Call Girls South Delhi 9999965857 Cheap and Best with original PhotosCall Girls South Delhi 9999965857 Cheap and Best with original Photos
Call Girls South Delhi 9999965857 Cheap and Best with original Photos
 
Globalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od DoveGlobalny raport: „Prawdziwe piękno 2024" od Dove
Globalny raport: „Prawdziwe piękno 2024" od Dove
 
Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 ) unlimited hard...
Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 )  unlimited hard...Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 )  unlimited hard...
Gurgaon Sushant Lok Phase 2 Call Girls Service ( 9873940964 ) unlimited hard...
 
Low Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptxLow Vision Case (Nisreen mokhanawala).pptx
Low Vision Case (Nisreen mokhanawala).pptx
 
Models Call Girls Electronic City | 7001305949 At Low Cost Cash Payment Booking
Models Call Girls Electronic City | 7001305949 At Low Cost Cash Payment BookingModels Call Girls Electronic City | 7001305949 At Low Cost Cash Payment Booking
Models Call Girls Electronic City | 7001305949 At Low Cost Cash Payment Booking
 
SARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdf
SARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdfSARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdf
SARS (SEVERE ACUTE RESPIRATORY SYNDROME).pdf
 
Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949Low Rate Call Girls In Bommanahalli Just Call 7001305949
Low Rate Call Girls In Bommanahalli Just Call 7001305949
 
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
2025 Inpatient Prospective Payment System (IPPS) Proposed Rule
 
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
Call Girls Service Bommasandra - Call 7001305949 Rs-3500 with A/C Room Cash o...
 
Call Girls Sawda 9999965857 Cheap and Best with original Photos
Call Girls Sawda 9999965857 Cheap and Best with original PhotosCall Girls Sawda 9999965857 Cheap and Best with original Photos
Call Girls Sawda 9999965857 Cheap and Best with original Photos
 
9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Delivery
9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Delivery9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Delivery
9711199012 Najafgarh Call Girls ₹5.5k With COD Free Home Delivery
 
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 45 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 HireCall Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
Call Girls Delhi 9873940964 Elite Escort Service Available 24/7 Hire
 
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
Gurgaon DLF Phase 5 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Fe...
 
Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
Gurgaon Sector 86 Call Girls ( 9873940964 ) Book Hot And Sexy Girls In A Few ...
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 

Understanding Statistical Power for Non-Statisticians

  • 1. Understanding Statistical Power for Non-Statisticians WEBINAR | JUNE 28, 2016 | 12:00PM EASTERN | DIA 2016 DALE W. USNER, PH.D. | PRESIDENT | SDC
  • 2. General Housekeeping  Use mic & speakers or call in  Webinar users submit questions via chat
  • 3. Dale W. Usner, Ph.D.  20 years in industry  50+ FDA and international regulatory body interactions  Frequent study design support  Therapeutic Expertise Anti-viral/Anti-infective, Cardiovascular, Gastrointestinal, Oncology/Immunology, Ophthalmology, Surgical, Other
  • 4. Agenda  What is Statistical Power  How Assumptions Affect Statistical Power and Sample Size  How Power Is Associated With What is Statistically Significant  Q&A
  • 6. What is Statistical Power?  Clinical/Medical: If I want to compare our Test Product to the Control Product in systolic blood pressure, what sample size will I need?  Statistician: Assuming a Difference in Means of 10 mm Hg and a common Standard Deviation (SD) of 20 mm Hg, 64 subjects per treatment group are required to have 80% power for a 2-sided  = 0.05 test.
  • 7. What is Statistical Power? Next?
  • 8. What is Statistical Power? Questions  What does it mean to have 80% power?
  • 9. What is Statistical Power? Questions  What does it mean to have 80% power?  What does it mean to assume a difference in means of 10 mm Hg? What if the true diff <10? >10?
  • 10. What is Statistical Power? Questions  What does it mean to have 80% power?  What does it mean to assume a difference in means of 10 mm Hg? What if the true diff <10? >10?  What role does the SD play? What if the true SD is >20? What if the true SD is <20?
  • 11. What is Statistical Power? Questions  What does it mean to have 80% power?  What does it mean to assume a difference in means of 10 mm Hg? What if the true diff <10? >10?  What role does the SD play? What if the true SD is >20? What if the true SD is <20?  What happens if the difference observed in the study is <10 mm Hg?
  • 12. Motivation  Assuming a Difference in Means of 10 mm Hg and a common SD of 20 mm Hg, N = 64 subjects per treatment group are required to have 80% power for a 2-sided  = 0.05 test.  The study will demonstrate a statistically significant result if the difference observed in the study is ≥7.0 mm Hg (assuming the observed SD is 20 mm Hg).
  • 13. Motivation  With 85% Power (N = 73 subjects / Tx Gp) observed differences ≥6.55 mm Hg would yield statistical significance  With 90% Power (N = 86 subjects / Tx Gp) observed differences ≥6.03 mm Hg would be statistical significance
  • 15. Statistical Inference  Statistical Inference: Drawing conclusions about an entire population based on a sample from that population.
  • 16. Hypotheses (Efficacy) Superiority  H0: Test Arm is no different from Control Arm  H1: Test Arm is different (superior) than Control Arm Non-Inferiority  H0: Test Arm is inferior to Control Arm  H1: Test Arm is non-inferior to Control Arm Desired Outcome: Reject H0 in favor of H1
  • 17. Statistical Inference: Coin Flip  H0: Proportion of Heads = Prop Tails = 0.50  H1: Proportion of Heads > Prop Tails  Flip a coin 4 times with result 3H and 1T. 75% Heads, should H0 be rejected?
  • 18. Statistical Inference: Coin Flip  H0: Proportion of Heads = Prop Tails = 0.50  H1: Proportion of Heads > Prop Tails  Flip a coin 4 times with result 3H and 1T. 75% Heads, should H0 be rejected?  No, probability of this occurring under H0 is 31.25%
  • 19. Statistical Inference: Coin Flip  H0: Proportion of Heads = Prop Tails = 0.50  H1: Proportion of Heads > Prop Tails  Flip a coin 4 times with result 3H and 1T. 75% Heads, should H0 be rejected?  No, probability of this occurring under H0 is 31.25%  Flip a coin 40 times with result 30H and 10T. 75% Heads, should H0 be rejected?
  • 20. Statistical Inference: Coin Flip  H0: Proportion of Heads = Prop Tails = 0.50  H1: Proportion of Heads > Prop Tails  Flip a coin 4 times with result 3H and 1T. 75% Heads, should H0 be rejected?  No, probability of this occurring under H0 is 31.25%  Flip a coin 40 times with result 30H and 10T. 75% Heads, should H0 be rejected?  Yes, probability of this occurring under H0 is <0.1%
  • 21. Define  and Power   (Type I Error) is the probability that the study concludes the Test Arm is different from the Control Arm, when the Test Arm truly is no different. This is a regulatory risk.  Power is the probability that the study concludes the Test Arm is different from the Control Arm, when in the Test Arm truly is different. This is sponsor risk.
  • 22. Continuous & Binary Measures  Continuous Measures  Generally testing differences in Means or Medians  Standard Deviation also very important  Binary Measures  Generally testing differences or ratios of proportions  Standard Deviations generally determined by assumed proportions
  • 23. Power in Pictures  Consider  a therapy designed to lower systolic blood pressure (SysBP) by an additional 10 mm Hg more than the currently best selling therapy, which has been shown to lower the SysBP to an average of 140 mm Hg.  that each treatment has an SD of 20 mm Hg  Assume the data follow normal distributions
  • 24. Power in Pictures: Sample Size = 1
  • 25. Power in Pictures: Sample Size = 5
  • 26. Power in Pictures: Sample Size = 10
  • 27. Power in Pictures: Sample Size = 30
  • 28. Power in Pictures: Sample Size = 50
  • 29. Power in Pictures: Sample Size = 64
  • 30. Power in Pictures: Sample Size = 73
  • 31. Power in Pictures: Sample Size = 86
  • 32. Power in Pictures: Sample Size = 1
  • 33. Power in Pictures: Sample Size = 5 Power: 10%
  • 34. Power in Pictures: Sample Size = 10 Power: 18%
  • 35. Power in Pictures: Sample Size = 30 Power: 47%
  • 36. Power in Pictures: Sample Size = 50 Power: 69%
  • 37. Power in Pictures: Sample Size = 64 Power: 80%
  • 38. Power in Pictures: Sample Size = 73 Power: 85%
  • 39. Power in Pictures: Sample Size = 86 Power: 90%
  • 40. Standard Powers  80%: If the test product is as efficacious as assumed under H1, 80% of trials should reject H0 in favor of H1 by design. Generally considered to be the lowest targeted power.  85%: 85% of trials should reject H0 in favor of H1 by design.  90%: 90% of trials should reject H0 in favor of H1 by design.
  • 41. Sponsor Risk  80%: If the test product is as efficacious as assumed under H1, 20% of trials will fail to reject H0 in favor of H1 by design.  85%: 15% of trials will fail to reject H0 in favor of H1 by design.  90%: 10% of trials will fail to reject H0 in favor of H1 by design.
  • 42. How Assumptions Affect Statistical Power and Sample Size
  • 43. Sample Size x Assumed Difference x Power 0 100 200 300 400 500 6 7 8 9 10 11 12 13 14 TotalSampleSize Assumed Difference SD = 20, 2-sided alpha = 0.05 80% Power 85% Power
  • 44. % Increase in Sample Size (N) for Increasing Power  Assuming a 2-sided  = 0.05 test, N increases by:  ~14% from 80% to 85% power  ~34% from 80% to 90% power  Assuming a 2-sided  = 0.10 test, N increases by  ~16% from 80% to 85% power  ~38% from 80% to 90% power  Assuming a 2-sided  = 0.20 test, N increases by  ~19% from 80% to 85% power  ~46% from 80% to 90% power
  • 45. Sample Size x Assumed Difference x Standard Deviation 0 100 200 300 400 500 600 6 7 8 9 10 11 12 13 14 TotalSampleSize Assumed Difference 80% Power, 2-sided alpha = 0.05 SD = 16 SD = 18 SD = 20 SD = 22
  • 46. % Increase in Sample Size (N) for Increasing Standard Deviation  Regardless of the  and power, N increases by a factor of (SDhigh / SDlow)2
  • 47. Sample Size x Assumed Difference x Alpha (Type I Error) 0 100 200 300 400 6 7 8 9 10 11 12 13 14 TotalSampleSize Assumed Difference SD = 20, 80% Power 2-sided alpha = 0.20 2-sided alpha = 0.10
  • 48. % Decrease in Sample Size (N) for Increasing Alpha (Type I Error)  Assuming 80% power, N decreases by:  ~21% from 2-sided alpha = 0.05 to 0.10  ~42% from 2-sided alpha = 0.05 to 0.20  Assuming 85% power, N decreases by:  ~20% from 2-sided alpha = 0.05 to 0.10  ~40% from 2-sided alpha = 0.05 to 0.20  Assuming 90% power, N decreases by:  ~18% from 2-sided alpha = 0.05 to 0.10  ~37% from 2-sided alpha = 0.05 to 0.20
  • 49. Sample Size x Assumed Difference x Power and Ratio of Randomization 0 100 200 300 400 500 600 6 7 8 9 10 11 12 13 14 TotalSampleSize Assumed Difference SD = 20, 2-sided alpha = 0.05 80% Power 80% Power 2:1 85% Power 85% Power 2:1
  • 50. % Increase in Sample Size (N) for Increasing Randomization Ratio  Regardless of the  and power, N increases by:  ~4.2% from 1:1 to 3:2 randomization ratio  ~12.5% from 1:1 to 2:1 randomization ratio  ~33.3% from 1:1 to 3:1 randomization ratio
  • 51. % Decrease in Min Obs Diff Required for Significance with Increasing N  Regardless of the , the Minimum Observed Difference required for Significance decreases by a factor of sqrt(Nlow / Nhigh)  With 80% Power, N = 64 / Tx Group required diff is 7.00 mm Hg  With 85% Power, N = 73 / Tx Group required diff is (7.00*sqrt(64/73)) = 6.55 mm Hg  With 90% Power, N = 86 / Tx Group required diff is (7.00*sqrt(64/86)) = 6.03 mm Hg
  • 52. Effect on Statistical Significance  Increasing Sample Size decreases the minimum difference required to show statistical significance (driven by H0) and therefore increases power.  Required sample size increases with:  Increasing: Power, SD, Randomization Ratio  Decreasing: Alpha, Assumed Difference